Live Vaccine Candidate News with Latest Updates

Live vaccine candidate news and developments with the latest updates. Check out current vaccine candidate news stories and find out what happened, what is going on with vaccine candidate. Recent news updates about vaccine candidate
Advantages of intranasal vaccination against Covid
Three Griffith scientists honoured as Young Tall Poppies
Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa
Valneva and Pfizer Complete Recruitment for Phase 2 Trial of Lyme Disease Vaccine Candidate
Research finds monoclonal antibodies that may neutralize many norovirus variants
Protein-based vaccine candidate combined with potent adjuvant yields effective SARS-CoV-2 protection
New COVID-19 vaccine candidate, option for low- to mid-income countries
Finnish coronavirus vaccine developer Rokote Laboratories Finland secures significant funding
HIV vaccine trial starts at Oxford
Self-amplifying RNA COVID-19 vaccine technology safe in humans, suggests study
COVID-19 vaccines show safety, immunity in infant model
$180 million in medical research to improve lives of Australians
Vaxzevria induced immunity for at least one year following a single dose and strong immune responses following either a late second
Victorian collaboration boosts coronavirus research
Minister Champagne marks completion of construction of Biologics Manufacturing Centre in Montréal
Breakthrough: Victoria Closer To Manufacturing Vaccine
Newly Released Trial Results Show Novavax COVID-19 Vaccine Highly Effective
Data and safety review board reports how it monitored COVID-19 vaccine trials
Two COVID-19 Vaccines Show Safety, Strong Immunity in Infant Model
U.S. FDA Approves PREVNAR 20, Pfizer’s Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or Older
NIH launches clinical trial of universal influenza vaccine candidate
Second-generation COVID-19 vaccine clinical trial starts at BCM
New vaccine provides promise to tackle sleeping sickness in Africa, study shows
Discovery of vaccine target for devastating livestock disease
CEPI funds Phase 3 trial of UW Medicine COVID-19 vaccine
Pfizer Initiates Study Exploring Coadministration of Its 20-valent Pneumococcal Conjugate Vaccine Candidate Along With a Third Dose of Pfizer-BioNTech COVID-19 Vaccine
7 in 10 UK adults receive first dose of coronavirus vaccine
Behind Covid-19 vaccine development
Sanofi and GSK advance COVID-19 vaccine to late-stage trial
Scientists find new way of predicting COVID-19 vaccine efficacy
MRFF grant to help fast-track Australian COVID-19 vaccine candidate
Jab-free dengue immunity could be just a click away
Researchers develop vaccine for human babesiosis
SA accelerates local COVID vaccine development for mutant strains
CSIRO publishes preclinical study results for Oxford-AstraZeneca vaccine
New Strep A human challenge model paves way to test vaccines against deadly bacteria
Canada’s increased contributions to ACT-Accelerator
Promising malaria vaccine enters final stage of clinical testing in West Africa
Still hesitant to get shot? 8 COVID vaccine concerns addressed
Biological E. Limited to begin Phase III clinical trials with Baylor and Texas Children’s vaccine
Canada invests in Vaccine and Infectious Disease Organization
Ministers Champagne, Joly and Carr highlight Budget 2021 biomanufacturing investments
Canada secures vaccine supply beyond 2021
Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal
MERS DNA vaccine induces immunity, protects from virus challenge in preclinical model
Feldman, Khader, Philips elected to American Academy of Microbiology
Large NIH clinical trial will test polyclonal antibody therapeutic for COVID-19
Monash University welcomes $50m Government funding for mRNA vaccine development and manufacturing